Solomon Islands Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Solomon Islands Health Reporter.

Press releases published on October 19, 2026

2 hours ago

Decamen App Launches Personalized Military-Style Home Workout Plan for Busy Men

Indeterminate GlobeNewswire

2 hours ago

Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026

Indeterminate GlobeNewswire

2 hours ago

Indivior to Report Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

2 hours ago

Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026

Indeterminate GlobeNewswire

2 hours ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Completion of Manufacturing Process Validation and Two-Year Stability of Preservative-Free Ketamine

Indeterminate GlobeNewswire

2 hours ago

Alpha Tau Announces FDA Approval to Expand Alpha DaRT® U.S. Recurrent Glioblastoma REGAIN Trial; New Trial Data to be Presented at SNO 2026 Annual Meeting

Indeterminate GlobeNewswire

2 hours ago

Dogwood Announces $5 Million Private Placement with CK Life Sciences Int’l., (Holdings) Inc.

Indeterminate GlobeNewswire

2 hours ago

J-Star Holding Co., Ltd. Advances U.S. Drone Manufacturing Initiative; Negotiates Acquisition of Facility in the Greater Houston Area

Indeterminate GlobeNewswire

2 hours ago

Enlivex Announces Cost Reduction Plan to Focus Resources on Phase 2b Trial of Allocetra™ in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Indeterminate GlobeNewswire

2 hours ago

Enable Injections Announces Approval in Japan for CirCLIQ® Injector based on enFuse® On-Body Delivery System

Indeterminate GlobeNewswire

2 hours ago

ArriVent Announces Cancer Cell Publication Highlighting Firmonertinib in EGFR PACC-Mutant Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire

2 hours ago

argenx to Present Phase 3 ALKIVIA Results in Autoimmune Myositis as a Late-Breaking Oral Presentation at ACR Convergence 2026

Indeterminate GlobeNewswire

2 hours ago

Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026

Indeterminate GlobeNewswire

2 hours ago

Nyxoah Annonce ses Résultats Préliminaires pour le Troisième Trimestre 2026 et Ajuste ses Prévisions de Chiffre d’Affaires pour 2026

Indeterminate GlobeNewswire

2 hours ago

GuideAI Health Enters Clinical Study and Software Pilot Agreement with Boone Heart Institute

Indeterminate GlobeNewswire

2 hours ago

Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS

Indeterminate GlobeNewswire

2 hours ago

Baird Medical Announces Regulatory Milestones in Vietnam and Egypt, Expanding International Reach of Microwave Ablation Technology

Indeterminate GlobeNewswire

2 hours ago

SpyGlass Pharma Announces Positive 4-Year Data From First-in-Human Trial of Its Innovative BIM-IOL System

Indeterminate GlobeNewswire

2 hours ago

UroGen Announces FDA Acceptance of the New Drug Application for UGN-103, an Investigational Treatment for Adults with Recurrent LG-IR-NMIBC

Indeterminate GlobeNewswire

2 hours ago

Calidi Biotherapeutics to Present New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026

Indeterminate GlobeNewswire